Full Name
Alan Prem Kumar
Variants
Kumar, A.P.
Kumar, A.
Prem Kumar, A.
Kumar, Alan Prem Rem
 
 
 
Email
apkumar@nus.edu.sg
 
Other emails
 

Publications

Refined By:
Department:  DEAN'S OFFICE (MEDICINE)

Results 81-100 of 159 (Search time: 0.015 seconds).

Issue DateTitleAuthor(s)
811-Jan-2018Molecular targets and anti-cancer potential of escinCheong, Dorothy HJ ; Arfuso, Frank; Sethi, Gautam ; Wang, Lingzhi ; Hui, Kam Man ; Kumar, Alan Prem ; Thai, Tran 
821-Sep-2021Multi-target weapons: diaryl-pyrazoline thiazolidinediones simultaneously targeting VEGFR-2 and HDAC cancer hallmarksUpadhyay, Neha; Tilekar, Kalpana; Safuan, Sabreena; Kumar, Alan P ; Schweipert, Markus; Meyer-Almes, Franz-Josef; Ramaa, CS
83Feb-2012Multifaceted link between cancer and inflammationSethi, G.; Shanmugam, M.K. ; Ramachandran, L.; Kumar, A.P. ; Tergaonkar, V.
842018N-substituted pyrido-1,4-Oxazin-3-ones induce apoptosis of hepatocellular carcinoma cells by targeting NF-?B signaling pathwayMohan, C.D; Bharathkumar, H; Dukanya, Department of Studies in Organic Chemistry, University of Mysore, Mysore, India; Rangappa, S; Shanmugam, M.K ; Chinnathambi, A; Alharbi, S.A; Alahmadi, T.A; Bhattacharjee, A; Lobie, P.E ; Deivasigamani, A; Hui, K.M; Sethi, G ; Basappa, Laboratory of Chemical Biology, Department of Chemistry, Bangalore University, Bangalore, India, Department of Studies in Organic Chemistry, University of Mysore, Mysore, India; Rangappa, K.S; Kumar, A.P 
8517-Jun-2022(Nano)platforms in bladder cancer therapy: Challenges and opportunitiesAshrafizadeh, Milad; Zarrabi, Ali; Karimi-Maleh, Hassan; Taheriazam, Afshin; Mirzaei, Sepideh; Hashemi, Mehrdad; Hushmandi, Kiavash; Makvandi, Pooyan; Nazarzadeh Zare, Ehsan; Sharifi, Esmaeel; Goel, Arul; Wang, Lingzhi ; Ren, Jun; Nuri Ertas, Yavuz; Kumar, Alan Prem ; Wang, Yuzhuo; Rabiee, Navid; Sethi, Gautam ; Ma, Zhaowu
861-Sep-2021New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilitiesAshrafizadeh, Milad; Mirzaei, Sepideh; Hashemi, Farid; Zarrabi, Ali; Zabolian, Amirhossein; Saleki, Hossein; Sharifzadeh, Seyed Omid; Soleymani, Leyla; Daneshi, Salman; Hushmandi, Kiavash; Khan, Haroon; Kumar, Alan Prem ; Aref, Amir Reza; Samarghandian, Saeed
872018NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistanceMonisha J.; Roy N.K.; Padmavathi G.; Banik K.; Bordoloi D.; Khwairakpam A.D.; Arfuso F.; Chinnathambi A.; Alahmadi T.A.; Alharbi S.A.; Sethi G. ; Kumar A.P. ; Kunnumakkara A.B.
88Apr-2012NHE-1: A promising target for novel anti-cancer therapeuticsLoo, S.Y.; Chang, M.K.X.; Chua, C.S.H.; Kumar, A.P. ; Pervaiz, S.; Clement, M.V. 
892015Non-invasive sensitive detection of KRAS and BRAF mutation in circulating tumor cells of colorectal cancer patientsDai X.; Ahn K.S.; Kim C.; Siveen K.S. ; Ong T.H.; Shanmugam M.K. ; Li F.; Shi J. ; ALAN PREM KUMAR ; Wang L.Z. ; Goh B.C. ; Magae J.; Hui K.M.; Sethi G. 
902018Novel 1,3,4-oxadiazole induces anticancer activity by targeting NF-κB in hepatocellular carcinoma cellsMohan, C.D; Anilkumar, N.C; Rangappa, S; Shanmugam, M.K ; Mishra, S ; Chinnathambi, A; Alharbi, S.A; Bhattacharjee, A; Sethi, G ; Kumar, A.P ; Basappa, Laboratory of Chemical Biology, Department of Chemistry, Bangalore University, Bangalore, India, Department of Studies in Organic Chemistry, University of Mysore, Mysore, India; Rangappa, K.S
912016Novel aromatase inhibitors selection using induced fit docking and extra precision methods: Potential clinical use in ER-alpha-positive breast cancer.Kumavath, Ranjith; Azad, Manan; Devarapalli, Pratap; Tiwari, Sandeep; Kar, Shreya; Barh, Debmalya; Azevedo, Vasco; Kumar, Alan Prem 
922015Novel phospholipase A2 inhibitors from python serum are potent peptide antibioticsSamy, Ramar Perumal Erumal ; Thwin, Maung Maung Aung; Stiles, Bradley G; Satyanarayana-Jois, Seetharama; Chinnathambi, Arunachalam; Alharbi, Sulaiman Ali Li; Siveen, Kodappully Sivaraman ; Sikka, Sakshi; ALAN PREM KUMAR ; Sethi, Gautam ; Lim, Hsiu Kim Lina 
9326-Feb-2021Nrf2 signaling pathway in chemoprotection and doxorubicin resistance: potential application in drug discoveryMirzaei, Sepideh; Zarrabi, Ali; Hashemi, Farid; Zabolian, Amirhossein; Saleki, Hossein; Azami, Negar; Hamzehlou, Soodeh; Farahani, Mahdi Vasheghani; Hushmandi, Kiavash; Ashrafizadeh, Milad; Khan, Haroon; Kumar, Alan Prem 
942007Oxidative repression of NHE1 gene expression involves iron-mediated caspase activityKumar, A.P. ; Chang, M.K.X. ; Clement, M.-V. ; Fliegel, L.; Pervaiz, S. 
9511-Dec-2020Pharmacological Inhibition of BAD Ser99 Phosphorylation Enhances the Efficacy of Cisplatin in Ovarian Cancer by Inhibition of Cancer Stem Cell-like BehaviorWang, Yanxin; Chiou, Yi-Shiou; Chong, Qing-Yun ; Zhang, Mengyi; Rangappa, Kanchuragoppal S; Ma, Lan; Zhu, Tao; Kumar, Alan Prem ; Huang, Ruby Yun-Ju ; Pandey, Vijay; Basappa; Lobie, Peter E
962019Pharmacological inhibition of TFF3 enhances sensitivity of CMS4 colorectal carcinoma to 5-fluorouracil through inhibition of p44/42 MAPKChen, R.-M. ; Chiou, Y.-S.; Chong, Q.-Y. ; Poh, H.-M.; Tan, T.-Z. ; Zhang, M.-Y.; Ma, L.; Zhu, T.; Pandey, V.; Salundi, B.; Prem Kumar, A. ; Lobie, P.E. 
9724-Mar-2022PI3K/AKT Signaling Tips the Balance of Cytoskeletal Forces for Cancer ProgressionDeng, Shuo ; Leong, Hin Chong ; Datta, Arpita ; Gopal, Vennila; Kumar, Alan Prem ; Yap, Celestial T 
981-Dec-2023PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancerGlaviano, A; Foo, ASC; Lam, HY ; Yap, KCH ; Jacot, W; Jones, RH; Eng, H ; Nair, MG; Makvandi, P; Geoerger, B; Kulke, MH; Baird, RD; Prabhu, JS; Carbone, D; Pecoraro, C; Teh, DBL; Sethi, G ; Cavalieri, V; Lin, KH; Javidi-Sharifi, NR; Toska, E; Davids, MS; Brown, JR; Diana, P; Stebbing, J; Fruman, DA; Kumar, AP 
9917-Feb-2021Plasma osteopontin as a biomarker of Alzheimer's disease and vascular cognitive impairmentChai, Yuek Ling ; Chong, Joyce R ; Raquib, Ainiah R ; Xu, Xin ; Hilal, Saima ; Venketasubramanian, Narayanaswamy; Tan, Boon Yeow ; Kumar, Alan P ; Sethi, Gautam ; Chen, Christopher P ; Lai, Mitchell KP 
1001-Sep-2011Plumbagin inhibits invasion and migration of breast and gastric cancer cells by downregulating the expression of chemokine receptor CXCR4Manu, K.A. ; Shanmugam, M.K. ; Rajendran, P.; Li, F.; Ramachandran, L.; Hay, H.S. ; Kannaiyan, R.; Swamy, S.N.; Vali, S.; Kapoor, S.; Ramesh, B.; Bist, P.; Koay, E.S.; Lim, L.H.K.; Ahn, K.S.; Kumar, A.P. ; Sethi, G.